| Product Code: ETC7904733 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary  | 
2 Introduction  | 
2.1 Key Highlights of the Report  | 
2.2 Report Description  | 
2.3 Market Scope & Segmentation  | 
2.4 Research Methodology  | 
2.5 Assumptions  | 
3 Latvia Artificial Intelligence In Drug Discovery Market Overview  | 
3.1 Latvia Country Macro Economic Indicators  | 
3.2 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 & 2031F  | 
3.3 Latvia Artificial Intelligence In Drug Discovery Market - Industry Life Cycle  | 
3.4 Latvia Artificial Intelligence In Drug Discovery Market - Porter's Five Forces  | 
3.5 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F  | 
3.6 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F  | 
3.7 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F  | 
4 Latvia Artificial Intelligence In Drug Discovery Market Dynamics  | 
4.1 Impact Analysis  | 
4.2 Market Drivers  | 
4.2.1 Increasing investments in research and development in the pharmaceutical industry  | 
4.2.2 Rising demand for innovative drug discovery solutions  | 
4.2.3 Government support and initiatives promoting AI in healthcare and drug discovery  | 
4.3 Market Restraints  | 
4.3.1 High costs associated with AI implementation and maintenance  | 
4.3.2 Lack of skilled professionals in AI and drug discovery field  | 
4.3.3 Data privacy and security concerns in healthcare and pharmaceutical sectors  | 
5 Latvia Artificial Intelligence In Drug Discovery Market Trends  | 
6 Latvia Artificial Intelligence In Drug Discovery Market, By Types  | 
6.1 Latvia Artificial Intelligence In Drug Discovery Market, By Application  | 
6.1.1 Overview and Analysis  | 
6.1.2 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Application, 2021- 2031F  | 
6.1.3 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Drug Optimization and Repurposing, 2021- 2031F  | 
6.1.4 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Preclinical Testing, 2021- 2031F  | 
6.1.5 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F  | 
6.2 Latvia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area  | 
6.2.1 Overview and Analysis  | 
6.2.2 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F  | 
6.2.3 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F  | 
6.2.4 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F  | 
6.2.5 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Metabolic DiseasesInfectious Diseases, 2021- 2031F  | 
6.2.6 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F  | 
6.3 Latvia Artificial Intelligence In Drug Discovery Market, By Component  | 
6.3.1 Overview and Analysis  | 
6.3.2 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Software, 2021- 2031F  | 
6.3.3 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Hardware, 2021- 2031F  | 
6.3.4 Latvia Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Services, 2021- 2031F  | 
7 Latvia Artificial Intelligence In Drug Discovery Market Import-Export Trade Statistics  | 
7.1 Latvia Artificial Intelligence In Drug Discovery Market Export to Major Countries  | 
7.2 Latvia Artificial Intelligence In Drug Discovery Market Imports from Major Countries  | 
8 Latvia Artificial Intelligence In Drug Discovery Market Key Performance Indicators  | 
8.1 Number of research collaborations between pharmaceutical companies and AI firms  | 
8.2 Percentage increase in AI adoption in drug discovery processes  | 
8.3 Number of AI-related patents filed in the healthcare sector  | 
8.4 Rate of successful drug discoveries using AI technologies  | 
8.5 Number of AI-focused educational programs and courses offered in Latvia  | 
9 Latvia Artificial Intelligence In Drug Discovery Market - Opportunity Assessment  | 
9.1 Latvia Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F  | 
9.2 Latvia Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F  | 
9.3 Latvia Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F  | 
10 Latvia Artificial Intelligence In Drug Discovery Market - Competitive Landscape  | 
10.1 Latvia Artificial Intelligence In Drug Discovery Market Revenue Share, By Companies, 2024  | 
10.2 Latvia Artificial Intelligence In Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters  | 
11 Company Profiles  | 
12 Recommendations  | 
13 Disclaimer  |